Extranodal NK/T cell lymphoma, nasal type: An updated overview
- 1 March 2021
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 159, 103237
Abstract
No abstract availableKeywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (2017/14880−3)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (2017/14880−3)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/14880−3)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/14880−3)
This publication has 143 references indexed in Scilit:
- Extranodal Nasal NK/T-Cell Lymphoma: A Rare Oral Presentation and FASN, CD44 and GLUT-1 ExpressionBrazilian Dental Journal, 2013
- Extranodal Natural Killer/T-cell lymphoma, nasal type: ‘midline lethal granuloma.’ A case reportHead & Face Medicine, 2013
- SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study GroupBlood, 2012
- Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analysesBlood, 2011
- Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institutionDiagnostic Pathology, 2011
- Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal typeBlood, 2010
- Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescentsBlood, 2009
- STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphomaLeukemia, 2009
- A Clinical Study of 115 Patients with Extranodal Natural Killer/T-cell Lymphoma, Nasal TypeClinical Oncology, 2008
- Effect of Positive Bone Marrow EBV In situ Hybridization in Staging and Survival of Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal-TypeClinical Cancer Research, 2007